Pressmeddelande

BioStock: Circio's CEO on the new strategy

Cision Publicerad: 16 May 2023 08:49

Circio, formerly known as Targovax, is a Norwegian immunotherapy company within RNA-based therapeutics. The company is focusing on circular RNA, which holds several advantages over mRNA, according to CEO Erik Digman Wiklund. The potential of circular RNA has been acknowledged by the industry, as the area is attracting a lot of interest and investments.

Watch the interview with Circio's CEO Erik Digman Wiklund at biostock.se.

https://www.biostock.se/en/2023/05/circios-ceo-on-the-new-strategy/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Nyheter om Circio

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!